Good MorningThe market was largely unmoved by the FOMC on Wednesday after the committee delivered a message that was little more than expected. The FOMC made note of the COVID-vaccines and their impact on the recovery. The committee also noted that labor markets were strengthening although there was still weakness in some areas of the economy. In regards to inflation, committee chairman Jerome Powell says the recent increases in prices are likely to continue although inflation will be transitory.
The after-hours action was a little different. Reports from Facebook, Ford, Ebay, and Apple grabbed the market’s attention and had shares moving. Reports were equally strong and point to an accelerating economic rebound but not all shares moved in the same direction. Action on Thursday could be more of the same sluggish sideways movement as the market digests the latest round of news.
Featured: Elon’s big $266,000 per second purchase (Ad) 
|
Medical | |
Shares of BioMarin Pharmaceutical (NASDAQ:BMRN) are trading at light volume as the company prepares to deliver its first quarter 2021 earnings report on April 29, 2021. BRMN stock is down considerably from its 52-week high of $131.94.
It’s always important to understand why a stock moves ... Read the Full Story |
|
From Our Partners | | Bill Poulos is offering his Smart Trade Options Checklist at no cost today - normally priced at $29.97.
It's a single-page, seven-point filter designed to help traders identify weak setups before placing any options trade. Print it, keep it at your desk, and run it before every trade. The download link expires soon. | | Download your free copy of the Smart Trade Options Checklist now |
|
Basic Materials | | Large-cap stocks Rio Tinto (NYSE: RIO), Goldman Sachs (NYSE: GS) and PayPal (NASDAQ: PYPL) are all forming potentially constructive price consolidations, and may be nearing buy points.
The old advice to “buy low and sell high” applies to stocks that are consolidating.
But that doesn&... Read the Full Story |
|
Retail/Wholesale | |
A year removed from its historic plunge into the $50's, fast-food restaurant operator Yum! Brands (NYSE:YUM) is approaching its record intraday high of $119.72 set back in August 2018.
The remarkable turnaround is a credit to the company's ability to adapt to the pandemic economy along with marke... Read the Full Story |
|
From Our Partners | | Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 is orchestrating what analyst Porter Stansberry calls a total U.S. money reset, bypassing conventional legal channels under the guise of national security.
The last time America reset its currency - under Nixon in the 1970s - it created an average of 1,300 new millionaires a day for over 50 years. Stansberry has identified three asset categories connected to Trump's initiative that could surge, plus his single top investment move. | | Watch the documentary briefing and find out which side you land on |
|
Technology | | One of the biggest pandemic winners last year was Shopify (NYSE:SHOP), a company that offers a software platform for retailers that helps them set up their stores online. The stock rallied over 179% in 2020 thanks to broad shifts in the retail landscape and unprecedented demand for e-commerce. Many ... Read the Full Story |
|
Markets | |
Juniper Networks Is Ready To Bounce Higher
We like Juniper Networks (NYSE: JNPR) for a lot of reasons and think the stock is ready to move higher. Not only is it well-positioned as a networking leader it is gaining relevance in the cloud as well, and it is one of the best dividend-paying stocks ... Read the Full Story |
|
From Our Partners | | Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the digital dollar. They gave us the timeline… 2025 to 2030. We're in that window right now.
Once the digital dollar launches, every transaction you make will be tracked. Your spending could be controlled. Your accounts could be frozen.
Over 4,500 investors have already used this legal backdoor to hold assets CBDCs can't freeze and generate yields the Federal Reserve can't touch. | | Watch how to access the legal backdoor before it closes. |
|
Retail/Wholesale | |
Domino’s Pizza (NASDAQ:DPZ) reports first-quarter earnings before the market opens on April 29. Right now, I can understand why some investors may think the thrill is gone. DPZ stock has made an impressive gain of 21% since March 5, 2021. That was after the stock dropped around 14% since the... Read the Full Story |
|
Retail/Wholesale | |
Haverty Furniture Company, What’s Not To Like
We’ve been bullish on the furniture industry and Haverty Furniture Company (NYSE: HVT) for a long time, since well before the pandemic. The trade war with China (remember that?) had the industry on the ropes because it is (or was) so heav... Read the Full Story |
|
Basic Materials | |
Ecolab Fails To Impress With Its Q1 Results
Ecolab (NYSE: ECL) has been one of our top reopening plays since the first of the year and it still is. The company is well-positioned not only as an institutional services company servicing the restaurant, hospitality, and travel industries but also a... Read the Full Story |
|
Finance | |
Like consumers, investors are always after a good bargain. Therefore, many like to seek out undervalued companies with low stock prices. Although a low stock price can have the makings of a 'bear trap', sometimes there are true bargains to be found.
And since corporate insiders are investors like... Read the Full Story |
|
Transportation | | JetBlue Airways (NASDAQ: JBLU) traded lower Tuesday following a better-than-expected first-quarter report.
Shares closed Tuesday at $20.12, down $0.45, or 2.19%.
In its report, the New York-based airline offered a promising glimpse of the current rebound in leisure travel, which could bode well ... Read the Full Story |
|
The Early Bird Stock Of The Day Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes for the treatment of hemolytic anemias. The company develops AG-946, a PK activator for treating lower-risk myelodysplastic syndrome and hemolytic anemias; and AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria. Its preclinical product is siRNA for the treatment of polycythemia vera, a rare blood disorder. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts. | | View Today's Stock Pick |
|
